A Phase IIIB, Observer-Blind, Randomized, Placebo-Controlled, Multi-Center Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine

Project: Research project

Project Details

StatusFinished
Effective start/end date7/9/18 → 7/8/20

Funding

  • Corixa Corporation ( Award # ): $8,250.00